Gene · 6548
Papers3,457
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,457
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cardiac Sodium/Hydrogen Exchanger (NHE11) as a Novel Potential Target for SGLT2i in Heart Failure: A Preliminary Study. | Pharmaceutics | 2022 | 36297433 | PubTator, text mining | PubMed |
| Squalamines in Blockade of Tumor-Associated Angiogenesis and Cancer Progression. | Cancers (Basel) | 2022 | 36291938 | PubTator, text mining | PubMed |
| Atypical Macropinocytosis Contributes to Malignant Progression: A Review of Recent Evidence in Endometrioid Endometrial Cancer Cells. | Cancers (Basel) | 2022 | 36291839 | PubTator, text mining | PubMed |
| Digging into the 3D Structure Predictions of AlphaFold2 with Low Confidence: Disorder and Beyond. | Biomolecules | 2022 | 36291675 | PubTator, text mining | PubMed |
| Modulation of Neutrophil Activity by Soluble Complement Cleavage Products-An In-Depth Analysis. | Cells | 2022 | 36291163 | PubTator, text mining | PubMed |
| Global mapping of GalNAc-T isoform-specificities and O-glycosylation site-occupancy in a tissue-forming human cell line. | Nat Commun | 2022 | 36270990 | PubTator, text mining | PubMed |
| Polarized NHE1 and SWELL1 regulate migration direction, efficiency and metastasis. | Nat Commun | 2022 | 36253369 | PubTator, text mining | PubMed |
| Cardiovascular and renal efficacy and safety of sodium-glucose cotransporter-2 inhibitors in patients without diabetes: a systematic review and meta-analysis of randomised placebo-controlled trials. | BMJ Open | 2022 | 36241355 | PubTator, text mining | PubMed |
| In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study. | Front Cardiovasc Med | 2022 | 36237914 | PubTator, text mining | PubMed |
| Changes in Proximal Tubular Reabsorption Modulate Microvascular Regulation via the TGF System. | Int J Mol Sci | 2022 | 36232506 | PubTator, text mining | PubMed |
| NSP4 and ORF9b of SARS-CoV-2 Induce Pro-Inflammatory Mitochondrial DNA Release in Inner Membrane-Derived Vesicles. | Cells | 2022 | 36230930 | PubTator, text mining | PubMed |
| In Vivo MRI-CEST Tumor pH Imaging Detects Resistance to Proton Pump Inhibitors in Human Prostate Cancer Murine Models. | Cancers (Basel) | 2022 | 36230838 | PubTator, text mining | PubMed |
| Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry. | Cancer Metastasis Rev | 2022 | 36224457 | PubTator, text mining | PubMed |
| Advances on genetic and genomic studies of ALV resistance. | J Anim Sci Biotechnol | 2022 | 36217167 | PubTator, text mining | PubMed |
| Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary. | Front Cardiovasc Med | 2022 | 36211584 | PubTator, text mining | PubMed |
| Network Toxicology Guided Mechanism Study on the Association between Thyroid Function and Exposures to Polychlorinated Biphenyls Mixture. | Biomed Res Int | 2022 | 36203481 | PubTator, text mining | PubMed |
| Discovery of a Potent and Highly Selective Dipeptidyl Peptidase IV and Carbonic Anhydrase Inhibitor as "Antidiabesity" Agents Based on Repurposing and Morphing of WB-4101. | J Med Chem | 2022 | 36201615 | PubTator, text mining | PubMed |
| Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome. | Nature | 2022 | 36198801 | PubTator, text mining | PubMed |
| Hypothalamic astrocytes control systemic glucose metabolism and energy balance. | Cell Metab | 2022 | 36198294 | PubTator, text mining | PubMed |
| New insights and advances of sodium-glucose cotransporter 2 inhibitors in heart failure. | Front Cardiovasc Med | 2022 | 36186974 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6548/papers?page=22